login
login
Image header Agence Europe
Europe Daily Bulletin No. 13241
Contents Publication in full By article 13 / 19
EU RESPONSE TO COVID-19 / Health

EU authorises BioNTech-Pfizer vaccine suitable for autumn vaccination campaigns

On Friday 1 September, the European Commission authorised the Covid-19 vaccine adapted to Comirnaty XBB.1.5, developed by BioNTech-Pfizer.

This vaccine, which targets the Omicron XBB.1.5 sub-variant, marks an important new step in the fight against the disease. This is the third adaptation of this vaccine to respond to new Covid-19 variants.

The vaccine has been approved for adults, children and infants aged over six months. In line with previous recommendations from the European Medicines...

Contents

ECONOMY - FINANCE - BUSINESS
SECTORAL POLICIES
COMMISSIONERS-DESIGNATE HEARINGS IN EUROPEAN PARLIAMENT
INSTITUTIONAL
EXTERNAL ACTION
EU RESPONSE TO COVID-19
NEWS BRIEFS